News

The Preterm Birth International Collaborative Global (PREBIC) recently released a major new publication supporting the need for biomarker-based testing for pre-term birth in Frontiers in Medicine.

NX Prenatal, a leading women’s healthcare company focused on the development of advanced prenatal diagnostic tests, is announcing a new clinical study that demonstrates the company’s first trimester pre-term birth test’s ability to predict the risk of spontaneous pre-term birth (sPTB) in nulliparous pregnant women.

The United States is facing a maternal mortality crisis, particularly among Black and Hispanic communities.

NX Prenatal, a leading women’s healthcare company focused on the development of advanced prenatal diagnostic tests, proudly announces the appointment of Paul Kortschak as Chief Executive Officer, effective April 1, 2024.

NX Prenatal, a leading women’s healthcare company focused on the development of advanced prenatal diagnostic tests, proudly announces the appointment of Scott Gleason as Chief Financial Officer, effective March 18, 2024.

NX Prenatal Selected to Present at the 2023 Women's Health Innovation Summit